Related Experiment Videos
Reduction of sympathetic hyperactivity by enalapril in patients with chronic renal failure
G Ligtenberg1, P J Blankestijn, P L Oey
1Department of Nephrology and Hypertension, University Hospital Utrecht, The Netherlands. gligtenb@digd.azu.nl
Insights
Angiotensin-converting enzyme (ACE) inhibition effectively lowers blood pressure and reduces sympathetic nerve activity in patients with chronic renal disease and hypertension. This contrasts with amlodipine, which lowers blood pressure but increases sympathetic activity.
Area of Science:
- Nephrology
- Cardiology
- Pharmacology
Background:
- Patients with chronic renal failure often experience cardiovascular issues.
- Angiotensin-converting enzyme (ACE) inhibition is known to mitigate cardiovascular risks.
- The precise mechanism, particularly concerning sympathetic nervous system activity, remains unclear.
Purpose of the Study:
- To investigate the impact of ACE inhibition on muscle sympathetic nerve activity (MSNA) in patients with hypertension and chronic renal failure.
- To compare the effects of enalapril (an ACE inhibitor) with amlodipine (a calcium-channel blocker) on sympathetic activity and blood pressure.
Main Methods:
- Muscle sympathetic nerve activity (MSNA) was measured in 14 hypertensive patients with chronic renal failure before, during, and after enalapril administration.
- Ten similar patients were studied before and during amlodipine treatment.
- Control groups of healthy subjects were included for comparison.
Main Results:
- Baseline MSNA was significantly higher in patients compared to controls.
- Enalapril treatment normalized blood pressure and reduced MSNA to control levels.
- Amlodipine treatment lowered blood pressure but increased MSNA.
- Baroreflex sensitivity remained unchanged with enalapril but was altered by amlodipine.
Conclusions:
- Elevated sympathetic activity is a key factor in hypertension associated with chronic kidney disease.
- ACE inhibition effectively controls hypertension by reducing sympathetic hyperactivity.
- Different antihypertensive medications have distinct effects on sympathetic nervous system activity.
Background:
Inhibition of angiotensin-converting enzyme (ACE) reduces the risk of cardiovascular problems in patients with chronic renal failure. This effect may be due in part to a decrease in sympathetic nervous activity, but no direct evidence of such an action is available.
Methods:
We studied muscle sympathetic-nerve activity in 14 patients with hypertension, chronic renal failure, and increased plasma renin activity before, during, and after administration of the ACE inhibitor enalapril. Ten other patients with similar clinical characteristics were studied before and during treatment with the calcium-channel blocker amlodipine. Normal subjects matched for age and weight were included in both studies.
Results:
At base line, mean (+/-SD) muscle sympathetic-nerve activity was higher in the group of patients who received enalapril than in the control subjects (35+/-17 vs. 19+/-9 bursts per minute, P=0.004). The baroreflex curve, which reflects changes in muscle sympathetic-nerve activity caused by manipulations of blood pressure with sodium nitroprusside and phenylephrine, was shifted to the right in the patients, but baroreflex sensitivity was similar to that in the control subjects (-2.1+/-1.9 and -2.7+/-1.3 bursts per minute per mm Hg, respectively; P=0.36). A single dose of the sympatholytic drug clonidine caused a greater fall in blood pressure in the patients than in the control subjects. Treatment with enalapril normalized blood pressure and muscle sympathetic-nerve activity (at 23+/-10 bursts per minute) in the patients and shifted the baroreflex curve to the left, reflecting normal blood-pressure levels, without significantly changing sensitivity (-2.3+/-1.8 bursts per minute per mm Hg, P=0.96). In the patients who received amlodipine, treatment also lowered blood pressure but increased muscle sympathetic-nerve activity, from 41+/-19 to 56+/-14 bursts per minute (P=0.02).
Conclusions:
Increased sympathetic activity contributes to hypertension in patients with chronic renal disease. ACE inhibition controls hypertension and decreases sympathetic hyperactivity.